View of In Silico Study of Indole–Tetrazole Hybrid Derivatives as Potential Breast Cancer Anticancer Candidates Through Molecular Docking Against HER2, ADMET Profile Prediction, and Drug-Likeness Assessment

Return to Article Details In Silico Study of Indole–Tetrazole Hybrid Derivatives as Potential Breast Cancer Anticancer Candidates Through Molecular Docking Against HER2, ADMET Profile Prediction, and Drug-Likeness Assessment Download Download PDF